Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.
Muggia FM, Chan KK, Russell C, Colombo N, Speyer JL, Sehgal K, Jeffers S, Sorich J, Leichman L, Beller U, et al.
Muggia FM, et al. Among authors: jeffers s.
Cancer Chemother Pharmacol. 1991;28(4):241-50. doi: 10.1007/BF00685529.
Cancer Chemother Pharmacol. 1991.
PMID: 1831736